Cargando…
Systematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation
BACKGROUND: In the last 4 years, four novel oral anticoagulants have been developed as alternatives to warfarin and antiplatelet agents for stroke prevention in atrial fibrillation (AF) patients. The objective of this review was to estimate the comparative effectiveness of all antithrombotic treatme...
Autores principales: | Tawfik, Amy, Bielecki, Joanna M, Krahn, Murray, Dorian, Paul, Hoch, Jeffrey S, Boon, Heather, Husereau, Don, Pechlivanoglou, Petros |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986689/ https://www.ncbi.nlm.nih.gov/pubmed/27570467 http://dx.doi.org/10.2147/CPAA.S105165 |
Ejemplares similares
-
Trials of Novel Oral Anticoagulants for Stroke Prevention In Patients with Non-valvular Atrial Fibrillation
por: Halperin, Jonathan L, et al.
Publicado: (2014) -
Screening for atrial fibrillation to prevent stroke: a meta-analysis
por: McIntyre, William F, et al.
Publicado: (2022) -
Early economic evaluation of emerging health technologies: protocol of a systematic review
por: Pham, Ba’, et al.
Publicado: (2014) -
Stroke Prevention in Patients with Atrial Fibrillation
por: Kowey, Peter R.
Publicado: (2018) -
Left Atrial Appendage Exclusion for Stroke Prevention in Atrial Fibrillation
por: Patel, Taral K., et al.
Publicado: (2012)